Advertisement

Hepatic angiomyolipoma with early drainage veins into the hepatic and portal vein

  • Ryota KiuchiEmail author
  • Takanori Sakaguchi
  • Ryo Kitajima
  • Satoru Furuhashi
  • Makoto Takeda
  • Takanori Hiraide
  • Yoshifumi Morita
  • Takasuke Ushio
  • Rei Ishikawa
  • Satoshi Baba
  • Hiroya Takeuchi
Case Report

Abstract

Hepatic angiomyolipoma (AML) is a rare stromal tumor composed of variable admixtures of thick-walled vessels, smooth muscles and adipose tissue. One of the specific radiological findings of hepatic AML is an early drainage vein noted via enhanced computed tomography (CT). We report a case of hepatic AML showing early drainage veins into both the hepatic and portal vein. The case involved a 46-year-old woman who was referred to our hospital because of a giant hepatic tumor. CT revealed well-enhanced 14 cm and 1 cm tumors in the left and right lobes, respectively. Magnetic resonance imaging demonstrated the existence of adipose tissues in the larger tumor. Hepatic arteriography revealed early drainage veins draining into both the hepatic and portal vein. Based on a diagnosis of hepatic AML, left hepatectomy and partial hepatectomy were performed. Pathology revealed both tumors as hepatic AML based on human melanoma black-45 immuno-positivity. Hepatic AML with early drainage veins into both the hepatic and portal vein is rare. The dilated and retrogressive vein drains the abundant arterial blood flow of the tumor. The finding of early drainage veins into not only the hepatic vein but also the portal vein should be helpful for diagnosing hepatic AMLs.

Keywords

Hepatic angiomyolipoma Early drainage vein Hepatic vein Portal vein 

Notes

Compliance with ethical standards

Conflict of interest

Ryota Kiuchi, Takanori Sakaguchi, Ryo Kitajima, Satoru Furuhashi, Makoto Takeda, Takanori Hiraide, Yoshifumi Morita, Takasuke Ushio, Rei Ishikawa, Satoshi Baba and Hiroya Takeuchi declare that we they have no conflict of interest.

Human/animal rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from all patients for being included in the study.

References

  1. 1.
    Goodman ZD, Ishak KG. Angiomyolipomas of the liver. Am J Surg Pathol. 1984;8:745–50.CrossRefGoogle Scholar
  2. 2.
    Ishak K. Mesenchymal tumors of the liver. In: Okuda K, Peters RL, editors. Hepatocellular carcinoma. New York: Wiley; 1976. pp. 228–304.Google Scholar
  3. 3.
    Zheng RQ, Kudo M. Hepatic angiomyolipoma: identification of an efferent vessel to be hepatic vein by contrast-enhanced harmonic ultrasound. Br J Radiol. 2005;78:956–60.CrossRefGoogle Scholar
  4. 4.
    Jeon TY, Kim SH, Lim HK, et al. Assessment of triple-phase CT findings for the differentiation of fat-deficient hepatic angiomyolipoma from hepatocellular carcinoma in non-cirrhotic liver. Eur J Radiol. 2010;73:601–6.CrossRefGoogle Scholar
  5. 5.
    Yoshioka M, Watanabe G, Uchinami H, et al. Hepatic angiomyolipoma: differential diagnosis from other liver tumors in a special reference to vascular imaging - importance of early drainage vein. Surg Case Rep. 2015;1:11.CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Saito Y, Shimada M, Utsunomiya T, et al. Hepatic epithelioid angiomyolipoma with arterioportal venous shunting mimicking hepatocellular carcinoma: report of a case. J Med Investig. 2013;60:262–6.CrossRefGoogle Scholar
  7. 7.
    Tsui WM, Colombari R, Portmann BC, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23:34–48.CrossRefGoogle Scholar
  8. 8.
    Martignoni G, Pea M, Reghellin D, et al. PEComas: the past, the present and the future. Virchows Arch. 2008;452:119–32.CrossRefGoogle Scholar
  9. 9.
    Weeks DA, Malott RL, Arnesen M, et al. Hepatic angiomyolipoma with striated granules and positivity with melanoma–specific antibody (HMB-45): a report of two cases. Ultrastruct Pathol. 1991;15:563–71.CrossRefGoogle Scholar
  10. 10.
    Makhlouf HR, Ishak KG, Shekar R, et al. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study. Arch Pathol Lab Med. 2002;126:49–55.Google Scholar
  11. 11.
    Kudo M, Okuno T, Tomita S, et al. Hepatic angiomyolipoma pre-operatively diagnosed by imaging. J Gastroenterol Hepatol. 1993;8:483–8.CrossRefGoogle Scholar
  12. 12.
    Ahmadi T, Itai Y, Takahashi M, et al. Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging. 1998;23:520–6.CrossRefGoogle Scholar
  13. 13.
    Yan F, Zeng M, Zhou K, et al. Hepatic angiomyolipoma: various appearances on two-phase contrast scanning of spiral CT. Eur J Radiol. 2002;41:12–8.CrossRefGoogle Scholar
  14. 14.
    Yoshimura H, Murakami T, Kim T, et al. Angiomyolipoma of the liver with least amount of fat component: imaging features of CT, MR, and angiography. Abdom Imaging. 2002;27:184–7.CrossRefGoogle Scholar
  15. 15.
    Wang S, Kuai X, Meng X, et al. Comparison of MRI features for the differentiation of hepatic angiomyolipoma from fat-containing hepatocellular carcinoma. Abdom Imaging. 2014;39:323–33.CrossRefGoogle Scholar
  16. 16.
    Iwao Y, Ojima H, Onaya H, et al. Early venous return in hepatic angiomyolipoma due to an intratumoral structure resembling an arteriovenous fistula. Hepatol Res. 2014;44:700–6.CrossRefGoogle Scholar
  17. 17.
    Murakami T, Nakamura H, Hori S, et al. Angiomyolipoma of the liver. Ultrasound, CT, MR imaging and angiography. Acta Radiol. 1993;34:392–4.CrossRefGoogle Scholar
  18. 18.
    Dalle I, Sciot R, de Vos R, et al. Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology. 2000;36:443–50.CrossRefGoogle Scholar
  19. 19.
    Mizuguchi T, Katsuramaki T, Nobuoka T, et al. Growth of hepatic angiomyolipoma indicating malignant potential. J Gastroenterol Hepatol. 2004;19:1328–30.CrossRefGoogle Scholar
  20. 20.
    Deng YF, Lin Q, Zhang SH, et al. Malignant angiomyolipoma in the liver: a case report with pathological and molecular analysis. Pathol Res Pract. 2008;204:911–8.CrossRefGoogle Scholar
  21. 21.
    Nguyen TT, Gorman B, Shields D, et al. Malignant hepatic angiomyolipoma: report of a case and review of literature. Am J Surg Pathol. 2008;32:793–8.CrossRefGoogle Scholar
  22. 22.
    Kamimura K, Oosaki A, Sugahara S, et al. Malignant potential of hepatic angiomyolipoma: case report and literature review. Clin J Gastroenterol. 2010;3:104–10.CrossRefGoogle Scholar
  23. 23.
    Fukuda Y, Omiya H, Takami K, et al. Malignant hepatic epithelioid angiomyolipoma with recurrence in the lung 7 years after hepatectomy: a case report and literature review. Surg Case Rep. 2016;2:31.CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol. 2002;26:493–7.CrossRefGoogle Scholar
  25. 25.
    Parfitt JR, Bella AJ, Izawa JI, et al. Malignant neoplasm of perivascular epithelioid cells of the liver. Arch Pathol Lab Med. 2006;130:1219–22.Google Scholar
  26. 26.
    Folpe AL, Mentzel T, Lehr H-AA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29:1558–75.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Gastroenterology 2019

Authors and Affiliations

  • Ryota Kiuchi
    • 1
    Email author
  • Takanori Sakaguchi
    • 1
  • Ryo Kitajima
    • 1
  • Satoru Furuhashi
    • 1
  • Makoto Takeda
    • 1
  • Takanori Hiraide
    • 1
  • Yoshifumi Morita
    • 1
  • Takasuke Ushio
    • 2
  • Rei Ishikawa
    • 3
  • Satoshi Baba
    • 3
  • Hiroya Takeuchi
    • 1
  1. 1.Second Department of SurgeryHamamatsu University School of MedicineHamamatsuJapan
  2. 2.Department of RadiologyHamamatsu University School of MedicineHamamatsuJapan
  3. 3.Department of Diagnostic PathologyHamamatsu University HospitalHamamatsuJapan

Personalised recommendations